NCT00978055View on ClinicalTrials.gov

Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg)

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Healthy
Interventions
DRUG

1: Liothyronine Sodium Tablets

"Liothyronine Sodium Tablets, 50 mcg~2 x 50 mcg, single-dose, fasting"

DRUG

2: Cytomel® Tablets

"Cytomel® Tablets, 50 mcg~2 x 50 mcg, single-dose, fasting"

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY